InsiderClue
Insiders · Profile

Cormorant Asset Management, LP

Former 10% Owner at BRIGHT MINDS BIOSCIENCES · 10% owner at Corbus Pharmaceuticals · Former 10% Owner at EyePoint · and 12 more. Filing since 29 May 2018. CIK 0001583977

DRUG BRIGHT MINDS BIOSCIENCES INC. Former 10% Owner · 4 trades CRBP Corbus Pharmaceuticals Holdings, Inc. 10% owner · 6 trades EYPT EyePoint, Inc. Former 10% Owner · 7 trades OKUR OnKure Therapeutics, Inc. Former 10% Owner · 2 trades AARD Aardvark Therapeutics, Inc. Former 10% Owner · 1 trade BIOA BioAge Labs, Inc. Former 10% Owner · 1 trade IMRX Immuneering Corp 10% owner · 4 trades PYXS Pyxis Oncology, Inc. Former 10% Owner · 1 trade TYRA Tyra Biosciences, Inc. Former 10% Owner · 1 trade JBIO Jade Biosciences, Inc. Former 10% Owner · 1 trade GLUE Monte Rosa Therapeutics, Inc. Former 10% Owner · 1 trade DSGN Design Therapeutics, Inc. Former 10% Owner · 1 trade BCAB BioAtla, Inc. Former 10% Owner · 1 trade OLMA Olema Pharmaceuticals, Inc. Former 10% Owner · 1 trade KNSA Kiniksa Pharmaceuticals International, plc 10% owner · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
DRUG BRIGHT MINDS BIOSCIENCES INC.
28 Apr 2026
Former 10% Owner
Sold at will
109,331
$9.79M
10.3%
CRBP Corbus Pharmaceuticals Holdings, Inc.
11 Dec 2025
10% owner
Sold at will
30,029
$344.01K
1.3%
EYPT EyePoint, Inc.
4 Dec 2025
Former 10% Owner
Sold at will
60,000
$942.24K
0.7%
OKUR OnKure Therapeutics, Inc.
15 May 2025
Former 10% Owner
Sold at will
1,813,439
$3.36M
100%
OKUR OnKure Therapeutics, Inc.
12 May 2025
10% owner
Sold at will
24,300
$48.24K
1.3%
AARD Aardvark Therapeutics, Inc.
14 Feb 2025
Former 10% Owner
Bought
187,500
$3.00M
23.4%
DRUG BRIGHT MINDS BIOSCIENCES INC.
4 Nov 2024
10% owner
Bought
184,331
$4.00M
21.1%
DRUG BRIGHT MINDS BIOSCIENCES INC.
16 Oct 2024
10% owner
Bought
50,000
$1.17M
6.1%
DRUG BRIGHT MINDS BIOSCIENCES INC.
15 Oct 2024
10% owner
Bought
372,591
$2.06M
82.4%
BIOA BioAge Labs, Inc.
27 Sep 2024
Former 10% Owner
Bought
450,000
$8.10M
38.2%
CRBP Corbus Pharmaceuticals Holdings, Inc.
20 Sep 2024
10% owner
Bought
350,000
$7.00M
17.3%
EYPT EyePoint, Inc.
6 May 2024
10% owner
Bought
850,000
$10.08M
11.4%
EYPT EyePoint, Inc.
18 Apr 2024
10% owner
Bought
581,765
$10.49M
8.4%
IMRX Immuneering Corp
1 Apr 2024
10% owner
Sold at will
400,000
$1.16M
12.1%
IMRX Immuneering Corp
15 Mar 2024
10% owner
Sold at will
400,000
$856.40K
10.8%
IMRX Immuneering Corp
14 Mar 2024
10% owner
Sold at will
509,091
$1.89M
12.1%
CRBP Corbus Pharmaceuticals Holdings, Inc.
8 Mar 2024
10% owner
Bought
300,000
$13.31M
17.4%
CRBP Corbus Pharmaceuticals Holdings, Inc.
7 Mar 2024
10% owner
Bought
250,000
$10.01M
16.9%
CRBP Corbus Pharmaceuticals Holdings, Inc.
2 Feb 2024
10% owner
Bought
750,000
$14.25M
103%
CRBP Corbus Pharmaceuticals Holdings, Inc.
26 Jan 2024
10% owner
Bought
282,632
$9.11M
63.9%
EYPT EyePoint, Inc.
11 Jan 2024
10% owner
Bought
750,000
$14.81M
12.2%
EYPT EyePoint, Inc.
9 Jan 2024
10% owner
Bought
105,000
$2.24M
1.7%
EYPT EyePoint, Inc.
8 Dec 2023
10% owner
Bought
588,235
$10.00M
10.8%
EYPT EyePoint, Inc.
4 Dec 2023
10% owner
Bought
1,919,057
$41.87M
54.3%
PYXS Pyxis Oncology, Inc.
13 Oct 2021
Former 10% Owner
Bought
450,000
$7.20M
67.3%
TYRA Tyra Biosciences, Inc.
17 Sep 2021
Former 10% Owner
Bought
312,500
$5.00M
41.3%
IMRX Immuneering Corp
3 Aug 2021
Former 10% Owner
Bought
550,000
$8.25M
32.3%
JBIO Jade Biosciences, Inc.
2 Jul 2021
Former 10% Owner
Bought
500,000
$7.00M
32.7%
GLUE Monte Rosa Therapeutics, Inc.
28 Jun 2021
Former 10% Owner
Bought
600,000
$11.40M
23.1%
DSGN Design Therapeutics, Inc.
30 Mar 2021
Former 10% Owner
Bought
750,000
$15.00M
17.2%
BCAB BioAtla, Inc.
18 Dec 2020
Former 10% Owner
Bought
800,000
$14.40M
53.6%
OLMA Olema Pharmaceuticals, Inc.
23 Nov 2020
Former 10% Owner
Bought
425,000
$8.08M
14.9%
KNSA Kiniksa Pharmaceuticals International, plc
29 May 2018
10% owner
Bought
69,444
$1.25M
8.4%
33 decisions on file.